BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
71.44
-1.39 (-1.91%)
At close: Mar 28, 2025, 4:00 PM
69.00
-2.44 (-3.42%)
Pre-market: Mar 31, 2025, 8:43 AM EDT

BioMarin Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
2,8542,4192,0961,8461,860
Upgrade
Revenue Growth (YoY)
17.97%15.42%13.53%-0.76%9.18%
Upgrade
Cost of Revenue
580.24532.06503.021,0991,152
Upgrade
Gross Profit
2,2741,8871,593746.97708.07
Upgrade
Selling, General & Admin
913.2892.41823.24759.38737.67
Upgrade
Research & Development
747.18746.77649.61--
Upgrade
Operating Expenses
1,7041,7011,538821.28799.83
Upgrade
Operating Income
570.04185.7754.68-74.32-91.76
Upgrade
Interest Expense
-12.67-17.34-15.97-15.34-29.31
Upgrade
Interest & Investment Income
74.8858.3418.0310.4816.61
Upgrade
Currency Exchange Gain (Loss)
-8.6-27.7-11.4--
Upgrade
Other Non Operating Income (Expenses)
3.932.09-2.0611.856.59
Upgrade
EBT Excluding Unusual Items
627.59201.1643.28-67.32-97.87
Upgrade
Merger & Restructuring Charges
-95.83----
Upgrade
Gain (Loss) on Sale of Investments
--12.6--0.55
Upgrade
Gain (Loss) on Sale of Assets
10-108-52.82
Upgrade
Other Unusual Items
---1.7-8.03-4.5
Upgrade
Pretax Income
541.76188.56149.58-75.35-49
Upgrade
Income Tax Expense
114.920.928.02-11.27-903.03
Upgrade
Net Income
426.86167.65141.56-64.08854.03
Upgrade
Net Income to Common
426.86167.65141.56-64.08854.03
Upgrade
Net Income Growth
154.62%18.43%---
Upgrade
Shares Outstanding (Basic)
190188185183181
Upgrade
Shares Outstanding (Diluted)
197192189183192
Upgrade
Shares Change (YoY)
2.67%1.39%3.34%-4.61%7.06%
Upgrade
EPS (Basic)
2.250.890.76-0.354.72
Upgrade
EPS (Diluted)
2.210.870.75-0.354.50
Upgrade
EPS Growth
153.71%16.00%---
Upgrade
Free Cash Flow
487.4262.5754.94208.96-28.95
Upgrade
Free Cash Flow Per Share
2.480.330.291.14-0.15
Upgrade
Gross Margin
79.67%78.01%76.00%40.46%38.06%
Upgrade
Operating Margin
19.97%7.68%2.61%-4.03%-4.93%
Upgrade
Profit Margin
14.96%6.93%6.75%-3.47%45.90%
Upgrade
Free Cash Flow Margin
17.08%2.59%2.62%11.32%-1.56%
Upgrade
EBITDA
666.47290.16156.6533.7213.41
Upgrade
EBITDA Margin
23.35%11.99%7.47%1.83%0.72%
Upgrade
D&A For EBITDA
96.43104.39101.97108.04105.17
Upgrade
EBIT
570.04185.7754.68-74.32-91.76
Upgrade
EBIT Margin
19.97%7.68%2.61%-4.03%-4.93%
Upgrade
Effective Tax Rate
21.21%11.09%5.36%--
Upgrade
Revenue as Reported
2,8542,4192,0961,8461,860
Upgrade
Advertising Expenses
34.527.825.230.2-
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q